Effect of Rosiglitazone on Overweight Subjects With Type 1 Diabetes
Effect of Rosiglitazone on Overweight Subjects With Type 1 Diabetes
About this item
Full title
Author / Creator
Publisher
Alexandria, VA: American Diabetes Association
Journal title
Language
English
Formats
Publication information
Publisher
Alexandria, VA: American Diabetes Association
Subjects
More information
Scope and Contents
Contents
OBJECTIVE:--To evaluate the safety and effectiveness of rosiglitazone in the treatment of overweight subjects with type 1 diabetes. RESEARCH DESIGN AND METHODS--A total of 50 adult type 1 diabetic subjects with a baseline BMI [>/=]27 kg/m² were randomly assigned in a double-blind fashion to take insulin and placebo (n = 25) or insulin and rosiglita...
Alternative Titles
Full title
Effect of Rosiglitazone on Overweight Subjects With Type 1 Diabetes
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracgeneralonefile_A134209966
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracgeneralonefile_A134209966
Other Identifiers
ISSN
0149-5992
E-ISSN
1935-5548
DOI
10.2337/diacare.28.7.1562
